Literature DB >> 35812023

Eosinophilic oesophagitis: improving diagnosis and therapy - reducing the burden of repeated endoscopy.

Anjan Dhar1, Hasan Haboubi2, Marcus Auth3, Stephen Attwood4.   

Abstract

Eosinophilic oesophagitis is now being diagnosed more often, although there continues to be a significant delay in the recognition of the condition in primary care, and among patients presenting with food bolus obstruction to other specialities like Ears, Nose and Throat and Accident & Emergency. The diagnosis requires endoscopy and biopsy, with six biopsies taken from at least two different areas of the oesophagus. The diagnostic threshold is > 15 eosinophils/high power field or 0.3 mm2. Dietary management although effective is often difficult to carry out due to poor adherence by patients and the need for a specialist dietitian and repeated biopsies. Orodispersible budesonide is very effective for inducing remission and maintaining it long term, with fewer biopsies. Newer targeted biological agents are promising in the treatment of patients who have not responded to conventional treatments. Dilatation of strictures in this condition is safe. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  DYSPHAGIA; ENDOSCOPY

Year:  2022        PMID: 35812023      PMCID: PMC9234720          DOI: 10.1136/flgastro-2022-102118

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  28 in total

1.  Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis.

Authors:  Amir F Kagalwalla; Timothy A Sentongo; Sally Ritz; Therese Hess; Suzanne P Nelson; Karan M Emerick; Hector Melin-Aldana; B U K Li
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-21       Impact factor: 11.382

Review 2.  Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.

Authors:  Á Arias; I Pérez-Martínez; J M Tenías; A J Lucendo
Journal:  Aliment Pharmacol Ther       Date:  2015-10-28       Impact factor: 8.171

3.  Eosinophilic esophagitis: historical perspective on an evolving disease.

Authors:  Stephen E Attwood; Glenn T Furuta
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

4.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

5.  Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study.

Authors:  Diego García-Compeán; José Alberto González González; César Antonio Marrufo García; Juan Pablo Flores Gutiérrez; Oralia Barboza Quintana; Gabriela Galindo Rodríguez; Miguel Angel Mar Ruiz; David de León Valdez; Joel Omar Jaquez Quintana; Héctor Jesús Maldonado Garza
Journal:  Dig Liver Dis       Date:  2010-09-16       Impact factor: 4.088

6.  Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.

Authors:  Emilio J Laserna-Mendieta; Sergio Casabona; Danila Guagnozzi; Edoardo Savarino; Antonia Perelló; Antonio Guardiola-Arévalo; Jesús Barrio; Isabel Pérez-Martínez; Anne Lund Krarup; Javier Alcedo; Susana de la Riva; Esther Rey-Iborra; Cecilio Santander; Ángel Arias; Alfredo J Lucendo
Journal:  Aliment Pharmacol Ther       Date:  2020-07-17       Impact factor: 8.171

7.  Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability.

Authors:  Bram D van Rhijn; Marijn J Warners; Wouter L Curvers; Anja U van Lent; Noor L Bekkali; R Bart Takkenberg; Jaap J Kloek; Jacques J G H M Bergman; Paul Fockens; Albert J Bredenoord
Journal:  Endoscopy       Date:  2014-09-10       Impact factor: 10.093

8.  Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis.

Authors:  Rachel F Harris; Calies Menard-Katcher; Dan Atkins; Glenn T Furuta; Mary D Klinnert
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-10       Impact factor: 2.839

9.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Authors:  Stephan Miehlke; Petr Hruz; Michael Vieth; Christian Bussmann; Ulrike von Arnim; Monther Bajbouj; Christoph Schlag; Ahmed Madisch; Christiane Fibbe; Henning Wittenburg; Hans Dieter Allescher; Max Reinshagen; Stefan Schubert; Jan Tack; Michaela Müller; Patrick Krummenerl; Joris Arts; Ralph Mueller; Karin Dilger; Roland Greinwald; Alex Straumann
Journal:  Gut       Date:  2015-03-19       Impact factor: 23.059

10.  Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy.

Authors:  Evan S Dellon; Olga Speck; Kimberly Woodward; Shannon Covey; Spencer Rusin; Nicholas J Shaheen; John T Woosley
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.